Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000352983> ?p ?o ?g. }
- W2000352983 endingPage "1948" @default.
- W2000352983 startingPage "1941" @default.
- W2000352983 abstract "Human flavin-dependent monooxygenase (FMO) isoforms 1 and 3 were expressed by retroviral gene transfer in mouse C3H/10T12 cells. FMO function was determined by the sulfoxidation of p-tolylmethylsulfide (TMS). Enzyme activity ranged from 4 to 30 nmol p-tolylmethylsulfoxide (TMSO)/30 min/mg cell protein for FMO 3 clones; for FMO 1 clones, the range was 1–6 nmol TMSO/30 min/mg. Cytotoxicity in these clones after exposure to thiocarbamate compounds was assessed by clonogenic assay. Thiourea (TU), phenylthiourea (PTU), and α-naphthylthiourea (ANTU) were toxic to FMO 3 cells but not to parental and FMO 1 clones; 50% toxicity was attained at 1×10−4 M TU, 5×10−6 M PTU, and 1×10−6 M ANTU. Toxicity was observed after a minimum exposure time of 6 hr. Parental cells were resistant to toxicity for exposure times spanning the entire clonogenic assay period (10 days). Ethylene thiourea (ETU) was not toxic to FMO 3 cells, but preincubation with 1×10−3 M ETU blocked TU toxicity. Reducing GSH levels by preincubation with 1×10−5 M buthionine sulfoxime (BSO) increased TU sensitivity in FMO 3 cells from 1×10−4 to 1×10−6 M to achieve 50% toxicity. BSO also increased the sensitivity of “low expressor” FMO 3 clones to TU, but did not alter the refractoriness of either parental or FMO 1 expressing cells to TU. N-Acetylcysteine afforded modest protection to TU toxicity by shifting 50% cytotoxicity for TU from 5×10−5 to 1×10−3 M. TU mutagenicity was assayed by the development of ouabain resistance in parental and FMO 3 C3H/10T12 cells. Exposure to N-methyl-N′-nitro-N-nitrosoguanidine (MNNG, direct acting mutagen) and TU was executed with and without prior sensitization with BSO. The mutation frequency for MNNG was 76/1×106 surviving cells, whereas no mutants were observed for TU-exposed cultures. The results of this study show that, in isolation, the major human hepatic form of FMO is capable of promoting thiocarbamate toxicity. Consistent with the known reactivity of thiocarbamate intermediates with GSH, treatments that alter GSH levels also altered toxicity in either the protective or sensitizing direction. These cell lines expressing variable levels of FMO 3 and TU sensitivity should prove useful as in vitro systems for dissecting the thiocarbamate toxicity pathway." @default.
- W2000352983 created "2016-06-24" @default.
- W2000352983 creator A5069368372 @default.
- W2000352983 creator A5088332392 @default.
- W2000352983 date "2002-06-01" @default.
- W2000352983 modified "2023-10-18" @default.
- W2000352983 title "Thiourea toxicity in mouse C3H/10T12 cells expressing human flavin-dependent monooxygenase 3" @default.
- W2000352983 cites W1535828429 @default.
- W2000352983 cites W1964770441 @default.
- W2000352983 cites W1985205911 @default.
- W2000352983 cites W2005846619 @default.
- W2000352983 cites W2010547715 @default.
- W2000352983 cites W2013826707 @default.
- W2000352983 cites W2029311148 @default.
- W2000352983 cites W2029453769 @default.
- W2000352983 cites W2034183276 @default.
- W2000352983 cites W2035838202 @default.
- W2000352983 cites W2041769533 @default.
- W2000352983 cites W2045798325 @default.
- W2000352983 cites W2053129342 @default.
- W2000352983 cites W2054100515 @default.
- W2000352983 cites W2057632915 @default.
- W2000352983 cites W2061595991 @default.
- W2000352983 cites W2061904825 @default.
- W2000352983 cites W2062725909 @default.
- W2000352983 cites W2065897415 @default.
- W2000352983 cites W2074117878 @default.
- W2000352983 cites W2077381724 @default.
- W2000352983 cites W2078798382 @default.
- W2000352983 cites W2089846954 @default.
- W2000352983 cites W2100536490 @default.
- W2000352983 cites W2102994840 @default.
- W2000352983 cites W2105834903 @default.
- W2000352983 cites W2109448546 @default.
- W2000352983 cites W2115629805 @default.
- W2000352983 cites W2417419750 @default.
- W2000352983 cites W2497438609 @default.
- W2000352983 doi "https://doi.org/10.1016/s0006-2952(02)00978-4" @default.
- W2000352983 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12093470" @default.
- W2000352983 hasPublicationYear "2002" @default.
- W2000352983 type Work @default.
- W2000352983 sameAs 2000352983 @default.
- W2000352983 citedByCount "44" @default.
- W2000352983 countsByYear W20003529832012 @default.
- W2000352983 countsByYear W20003529832013 @default.
- W2000352983 countsByYear W20003529832014 @default.
- W2000352983 countsByYear W20003529832015 @default.
- W2000352983 countsByYear W20003529832016 @default.
- W2000352983 countsByYear W20003529832017 @default.
- W2000352983 countsByYear W20003529832018 @default.
- W2000352983 countsByYear W20003529832020 @default.
- W2000352983 countsByYear W20003529832021 @default.
- W2000352983 countsByYear W20003529832022 @default.
- W2000352983 countsByYear W20003529832023 @default.
- W2000352983 crossrefType "journal-article" @default.
- W2000352983 hasAuthorship W2000352983A5069368372 @default.
- W2000352983 hasAuthorship W2000352983A5088332392 @default.
- W2000352983 hasConcept C109316439 @default.
- W2000352983 hasConcept C117262875 @default.
- W2000352983 hasConcept C13002179 @default.
- W2000352983 hasConcept C153911025 @default.
- W2000352983 hasConcept C178790620 @default.
- W2000352983 hasConcept C181199279 @default.
- W2000352983 hasConcept C185592680 @default.
- W2000352983 hasConcept C202751555 @default.
- W2000352983 hasConcept C2780520622 @default.
- W2000352983 hasConcept C2780538656 @default.
- W2000352983 hasConcept C29730261 @default.
- W2000352983 hasConcept C526171541 @default.
- W2000352983 hasConcept C55493867 @default.
- W2000352983 hasConcept C86803240 @default.
- W2000352983 hasConceptScore W2000352983C109316439 @default.
- W2000352983 hasConceptScore W2000352983C117262875 @default.
- W2000352983 hasConceptScore W2000352983C13002179 @default.
- W2000352983 hasConceptScore W2000352983C153911025 @default.
- W2000352983 hasConceptScore W2000352983C178790620 @default.
- W2000352983 hasConceptScore W2000352983C181199279 @default.
- W2000352983 hasConceptScore W2000352983C185592680 @default.
- W2000352983 hasConceptScore W2000352983C202751555 @default.
- W2000352983 hasConceptScore W2000352983C2780520622 @default.
- W2000352983 hasConceptScore W2000352983C2780538656 @default.
- W2000352983 hasConceptScore W2000352983C29730261 @default.
- W2000352983 hasConceptScore W2000352983C526171541 @default.
- W2000352983 hasConceptScore W2000352983C55493867 @default.
- W2000352983 hasConceptScore W2000352983C86803240 @default.
- W2000352983 hasIssue "11" @default.
- W2000352983 hasLocation W20003529831 @default.
- W2000352983 hasLocation W20003529832 @default.
- W2000352983 hasOpenAccess W2000352983 @default.
- W2000352983 hasPrimaryLocation W20003529831 @default.
- W2000352983 hasRelatedWork W1964403326 @default.
- W2000352983 hasRelatedWork W2000352983 @default.
- W2000352983 hasRelatedWork W2042117819 @default.
- W2000352983 hasRelatedWork W2044461168 @default.
- W2000352983 hasRelatedWork W2070317913 @default.
- W2000352983 hasRelatedWork W2139026216 @default.
- W2000352983 hasRelatedWork W2166139070 @default.
- W2000352983 hasRelatedWork W2320706841 @default.